124 related articles for article (PubMed ID: 36734441)
1. Clinical significance and effect of PRR 11 up-regulation on the malignancy of osteosarcoma.
Tan R; Zhao C; Lu Y; Chen L
Pol J Pathol; 2022; 73(3):264-276. PubMed ID: 36734441
[TBL] [Abstract][Full Text] [Related]
2. USP22 as a key regulator of glycolysis pathway in osteosarcoma: insights from bioinformatics and experimental approaches.
Zhang Q; Zhu J; Xie J; Gu Y; Chen L
PeerJ; 2024; 12():e17397. PubMed ID: 38784391
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of PRR11 affects the proliferation, migration and invasion of osteosarcoma by inhibiting the Wnt/β-catenin pathway.
Li K; Yu H; Zhao C; Li J; Tan R; Chen L
J Cancer; 2021; 12(22):6656-6664. PubMed ID: 34659555
[No Abstract] [Full Text] [Related]
4. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
5. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
[TBL] [Abstract][Full Text] [Related]
6. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
7. MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma.
Yi X; Wang Y; Xu S
J Orthop Surg Res; 2020 Oct; 15(1):454. PubMed ID: 33008443
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of targeting
Tang X; Luo L; Li Y; Wu H; Hu Q; Yue H; He X; Zou J; Min S
Aging (Albany NY); 2020 Dec; 13(1):1212-1235. PubMed ID: 33291071
[TBL] [Abstract][Full Text] [Related]
9. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonic irradiation and SonoVue microbubbles-mediated RNA interference targeting PRR11 inhibits breast cancer cells proliferation and metastasis, but promotes apoptosis.
Luo H; Li J; Lin Q; Xiao X; Shi Y; Ye X; Wei Z; Liu Y; Xu J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33057583
[TBL] [Abstract][Full Text] [Related]
11. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration.
Han LP; Wang CP; Han SL
Med Sci (Paris); 2018 Oct; 34 Focus issue F1():81-86. PubMed ID: 30403180
[TBL] [Abstract][Full Text] [Related]
13. miR‑23b‑3p promotes the apoptosis and inhibits the proliferation and invasion of osteosarcoma cells by targeting SIX1.
Liu H; Wei W; Wang X; Guan X; Chen Q; Pu Z; Xu X; Wei A
Mol Med Rep; 2018 Dec; 18(6):5683-5692. PubMed ID: 30387818
[TBL] [Abstract][Full Text] [Related]
14. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL
J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526
[TBL] [Abstract][Full Text] [Related]
15. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
Qin Y; Ye J; Zhao F; Hu S; Wang S
Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
[TBL] [Abstract][Full Text] [Related]
16. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
Jiang H; Guo W; Yuan S; Song L
Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
18. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.
Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y
FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410
[TBL] [Abstract][Full Text] [Related]
19. Effect of lncRNA LET on proliferation and invasion of osteosarcoma cells.
Kong G; Qi XJ; Wang JF
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1609-1614. PubMed ID: 29630103
[TBL] [Abstract][Full Text] [Related]
20. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
Zhou Y; Feng D; Gu X; Gao A; Liu Y
Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
